InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: Tiger Money post# 215

Monday, 06/21/2021 1:22:43 PM

Monday, June 21, 2021 1:22:43 PM

Post# of 1098
JJ knows exactly what he's doing. So even at this pps, half the proposed BRPA deal price, he is sitting on $400M. He's done/successful/rich.

Shareholders here and @ RLF have been continuously screwed unless they have flipped to a profit after one pump or another. The feud and costly Delays seem to continue.*

I Expected!!! that the EAP data had been crunched already and presented WITH the CT data.
FDA may take as long as two months from application and NOW they will have to review the EAP data as 'supplemental supporting data' as well. More delays.
Questionable EUA may now need changing to full FDA approval review, IMO.

The Inhaler is using a slightly different formulation of RLF-100 IV.?. More shelf stable 'nebulized' formulation, but still needing sub-zero logistics.

They NEED to show Progress on the 'dry powder' formulations for future Inhaler use and CTs...ASAP.

Are ALL the data sets finally given to RLF for EMA? Will JJ stick his **** into that too?


*Historic betrayal issues.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NRXP News